Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Short term Debt (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Short term Debt for 7 consecutive years, with $14.0 million as the latest value for Q1 2026.

  • Quarterly Short term Debt fell 39.13% to $14.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $14.0 million through Jan 2026, down 39.13% year-over-year, with the annual reading at $14.0 million for FY2026, 39.13% down from the prior year.
  • Short term Debt for Q1 2026 was $14.0 million at Usana Health Sciences, down from $23.0 million in the prior quarter.
  • The five-year high for Short term Debt was $23.0 million in Q4 2024, with the low at $786000.0 in Q4 2023.
  • Average Short term Debt over 5 years is $12.0 million, with a median of $12.0 million recorded in 2022.
  • The sharpest move saw Short term Debt surged 2826.21% in 2024, then crashed 39.13% in 2026.
  • Over 5 years, Short term Debt stood at $10.0 million in 2022, then crashed by 92.14% to $786000.0 in 2023, then skyrocketed by 2826.21% to $23.0 million in 2024, then changed by 0.0% to $23.0 million in 2025, then tumbled by 39.13% to $14.0 million in 2026.
  • According to Business Quant data, Short term Debt over the past three periods came in at $14.0 million, $23.0 million, and $23.0 million for Q1 2026, Q1 2025, and Q4 2024 respectively.